Coherus BioSciences
CHRS
$2.06
Share price
0.98%
Change (1 day)
-71.51%
Change (1 year)
Categories
Coherus BioSciences (CHRS) Fails to deliver data
Key failure to deliver metrics for Coherus BioSciences :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.31 M
- Last 3 months FTD volume: $3.85 M
- Last year FTD volume: $16.48 M
Failures to deliver for Coherus BioSciences (CHRS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Coherus BioSciences (CHRS) - since 2014
Volume in USD (price x number of shares), data since 2014Coherus BioSciences (CHRS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $2.76 M | -81.72% |
| 2023 | $15.13 M | 203.14% |
| 2022 | $4.99 M | -3.35% |
| 2021 | $5.16 M | -85.14% |
| 2020 | $34.75 M | 659.1% |
| 2019 | $4.57 M | -79.64% |
| 2018 | $22.49 M | -5.08% |
| 2017 | $23.69 M | 25.31% |
| 2016 | $18.91 M | -5.73% |
| 2015 | $20.06 M | 5426.91% |
| 2014 | $0.36 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Repligen
RGEN | $8.5 M | $0.10 B | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | N/A | $0.02 M | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | $0.21 B | 🇺🇸 USA |